Related Experiment Video
Updated: Jan 28, 2026
05:06
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
14.3K
PET-Based Imaging of Ischemic Heart Disease
Kevin Chen1, Edward J Miller1, Mehran M Sadeghi2
1Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
PET Clinics
|March 4, 2019
Summary
Positron emission tomography (PET) cardiac imaging offers superior accuracy for diagnosing coronary artery disease and assessing prognosis compared to traditional methods. It provides valuable insights into myocardial blood flow and microvascular function.
Area of Science:
- Cardiovascular Nuclear Imaging
- Ischemic Heart Disease Management
- Molecular Cardiovascular Imaging
Background:
- Cardiac nuclear imaging is crucial for managing ischemic heart disease.
- Conventional methods like SPECT have limitations in accuracy and prognostic assessment.
- Positron emission tomography (PET) offers advanced capabilities.
Purpose of the Study:
- To review the utility of PET in ischemic heart disease.
- To highlight PET's advantages over conventional imaging techniques.
- To discuss emerging PET applications in cardiovascular disease.
Main Methods:
- Review of current literature on PET in ischemic heart disease.
- Comparison of PET with single-photon emission CT (SPECT) myocardial perfusion imaging.
- Discussion of PET-based assessments including myocardial blood flow and coronary flow reserve.
Main Results:
- PET demonstrates superior accuracy in diagnosing coronary artery disease compared to SPECT.
- Incorporation of myocardial blood flow and coronary flow reserve enhances prognostic assessment.
- PET is valuable for assessing myocardial viability in ischemic cardiomyopathy.
Conclusions:
- PET-based cardiac imaging is a powerful tool for ischemic heart disease.
- PET offers enhanced diagnostic and prognostic capabilities, including microvascular disease assessment.
- Future developments in PET tracers and molecular imaging promise further advancements.
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
Related Concept Videos
01:17Ischemic Heart Disease: Overview
3.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
01:23Rheumatic Heart Disease I: Introduction
510
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
510
01:20Rheumatic Heart Disease IV: Nursing Management
324
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
324
01:21Rheumatic Heart Disease III: Medical Management
348
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
348
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
570
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
570
01:27Anatomy of the Heart
119.7K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.7K